# 21 CFR 310.100 New drug status opinions; statement of policy.

21 CFR 310.100 New drug status opinions; statement of policy., “New drug status opinions; statement of policy”, is a CFR section of [21 CFR Part 310, Subpart B—Specific Administrative Rulings and Decisions](https://ontology.bommaritollc.com/id/01a0f094-b5e8-7546-bf18-61be6931b775); in force.

IRI: <https://ontology.bommaritollc.com/id/01a0f094-c471-779f-bf2e-1cd054a5418d>

Within: [Title 21—Food and Drugs](https://ontology.bommaritollc.com/id/01a0f094-b437-7426-9a1d-f0a9f3d3e1aa) › [21 CFR Chapter I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES](https://ontology.bommaritollc.com/id/01a0f094-b455-74b7-9458-ed95d7b5ea58) › [21 CFR Chapter I, Subchapter D—DRUGS FOR HUMAN USE](https://ontology.bommaritollc.com/id/01a0f094-b5e4-722f-99b0-5c1856aef2a9) › [21 CFR Part 310—New drugs](https://ontology.bommaritollc.com/id/01a0f094-b84b-778f-b9bc-316d7d439b85) › [21 CFR Part 310, Subpart B—Specific Administrative Rulings and Decisions](https://ontology.bommaritollc.com/id/01a0f094-b5e8-7546-bf18-61be6931b775)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [cfr-section 21 CFR 310.100](https://ontology.bommaritollc.com/id/01a0f094-c472-7628-8431-030b33ac729f)
- `eli:cites`: [Pub. L. 87-781](https://ontology.bommaritollc.com/id/01a0f06c-d277-745c-b0ca-9efb3d92cc8a)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/CFR-2025-title21-vol1](https://ontology.bommaritollc.com/id/01a0f094-c471-779f-bf2e-1ccfa9404d53)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f094-e309-75e4-bdae-42c0d93e928c)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0d0-c4c2-7110-bf13-55fd6b514c67)
  - [evidence from https://www.govinfo.gov/link/cfr/21/310?sectionnum=100&year=mostrecent&link-type=details](https://ontology.bommaritollc.com/id/01a10f17-67a5-7372-9b6d-530f7f1b3409)
- `schema:isPartOf`: [21 CFR Part 310, Subpart B—Specific Administrative Rulings and Decisions](https://ontology.bommaritollc.com/id/01a0f094-b5e8-7546-bf18-61be6931b775)
- `schema:legislationIdentifier`: 21 CFR 310.100
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [CFR section](https://ontology.bommaritollc.com/vocab/leg/cfrSection)
- `schema:name`: New drug status opinions; statement of policy
- `schema:url`: [https://www.govinfo.gov/link/cfr/21/310?sectionnum=100&year=mostrecent&link-type=details](https://www.govinfo.gov/link/cfr/21/310?sectionnum=100&year=mostrecent&link-type=details)
- `skos:prefLabel`: 21 CFR 310.100 New drug status opinions; statement of policy.

## Elsewhere

- [Official page](https://www.govinfo.gov/link/cfr/21/310?sectionnum=100&year=mostrecent&link-type=details) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/CFR-2025-title21-vol1) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f094-c471-779f-bf2e-1cd054a5418d.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f094-c471-779f-bf2e-1cd054a5418d.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f094-c471-779f-bf2e-1cd054a5418d.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f094-c471-779f-bf2e-1cd054a5418d)
Cite as: 21 CFR 310.100 New drug status opinions; statement of policy.. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f094-c471-779f-bf2e-1cd054a5418d
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
